“…Since the effectiveness of medication can vary based on demographics, the ability to test cells from specific demographics is also an important tool for pharmacology [ 10 , 94 , 96 , 101 , 115 , 116 ]. In addition, lab-on-a-chip allows for the simulation of various cardiovascular disease conditions at the cellular level that can mimic behavior at the tissue and potentially the whole organ level [ 7 , 8 , 10 , 31 , 94 , 96 , 101 , 110 , 114 , 115 , 116 ]. Drug screening for cardiovascular disease is another potential application where lab-on-a-chip will no doubt be useful for the future as the lab-on-a-chip testing platform can allow for cellular-based drug toxicity studies [ 101 , 115 ].…”